Ionized calcium was involved in various cellular signal pathways,and regulates many cellular processes, including those relevant to tumorigenesis. We hypothesis that imbalance of calcium homeostasis is correlated with development of lung carcinomas. We collected the clinical data of 1084 patients with non small cell lung cancer (NSCLC) treated in Shandong Provincial Hospital, Shandong University. Logistic regression was used to determine the association between calcium levels and clinical characteristics, and COX regression and Kaplan-Meier model were applied to analyze risk factors on overall survival. Blood electrolytes were tested before treatment; and nearly 16% patients with NSCLC were complained with decreased blood calcium, which is more frequent than that in other electrolytes. Further, Multivariate logistic regression analysis disclosed that there were significant correlation between blood calcium decrease and moderate and poor differentiation (P = 0.012, OR = 1.926 (1.203–4.219)), squamous cell carcinoma (P = 0.024, OR = 1.968(1.094–3.540)), and bone metastasis (P = 0.032, OR = 0.396(0.235–0.669)). In multivariate COX regression analysis, advanced lymph node stage and decreased blood calcium were significantly and independent, unfavorable prognostic factors (P<0.001). Finally, the Kaplan-Meier Survival curve revealed that blood calcium decrease was associated with shorter survival (Log-rank; χ2 = 26.172,P<0.001). Our finding indicates that lower blood calcium levels are associated with a higher risk of unfavorable prognosis and bone metastasis of NSCLC.
References
[1]
Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. (2009) Cancer statistics, 2009. CA Cancer J Clin 59: 225–249.
Golovina VA, Blaustein MP (1997) Spatially and functionally distinct Ca2+ stores in sarcoplasmic and endoplasmic reticulum. Science 275: 1643–1648.
[4]
Rizzuto R, Pozzan T (2006) Microdomains of intracellular Ca2+: molecular determinants and functional consequences. Physiol Rev 86: 369–408.
[5]
Rizzuto Rosario, Pinton Paolo, Ferrari Davide, Chami Mounia, Szabadkai Gy？rgy, et al. (2003) Calcium and apoptosis: facts and hypotheses. Oncogene 22: 8619–8627.
[6]
Berridge MJ (1997) The AM and FM of calcium signalling. Nature 386: 759–760.
[7]
Lipskaia L, Lompre AM (2004) Alteration in temporal kinetics of Ca2+ signaling and control of growth and proliferation. Biol Cell 96: 55–68.
[8]
Govindasamy A, Gopa B, Hindupur K, Camasamudram V, Henry MS, et al. (2002) Mitochondrial stress-induced calcium signaling, phenotypic changes and invasive behavior in human lung carcinoma A549 cells. Oncogene 21: 7839–7849.
[9]
Huang JB, Kindzelskii AL, Clark AJ, Petty HR (2004) Identification of channels promoting calcium spikes and waves in HT1080 tumor cells: their apparent roles in cell motility and invasion. Cancer Res 64: 2482–2489.
[10]
Liao J, Schneider A, Datta NS, McCauley LK (2006) Extracellular calcium as a candidate mediator of prostate cancer skeletal metastasis. Cancer Res 66: 9065–9073.
[11]
Patton AM, Kassis J, Doong H, Kohn EC (2003) Calcium as a molecular target in angiogenesis. Curr Pharm Des 9: 543–551.
[12]
Bentle MS, Reinicke KE, Bey EA, Spitz DR, Boothman DA (2006) Calcium-dependent modulation of poly (ADP-ribose) polymerase-1 alters cellular metabolism and DNA repair. J Biol Chem 281: 33684–33696.
[13]
Bikle DD, Oda Y, Xie Z (2004) Calcium and 1,25(OH)2D: interacting drivers of epidermal differentiation. J Steroid Biochem Mol Biol 89–90: 355–360.
[14]
Cullen PJ, Lockyer PJ (2002) Integration of calcium and Ras signalling. Nature Rev. Mol Cell Biol 3: 339–348.
[15]
Pinton P, Rizzuto R (2006) Bcl-2 and Ca2+ homeostasis in the endoplasmic reticulum. Cell Death Differ 13: 1409–1418.
[16]
Ahn J, Albanes D, Peters U, Schatzkin A, Lim U, et al. (2007) Dairy products, calcium intake, and risk of prostate cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev 16: 2623–2630.
[17]
Halthur C, Johansson AL, Almquist M, Malm J, Gronberg H, et al. (2009) Serum calcium and the risk of prostate cancer. Cancer Causes Control 20: 1205–1214.
[18]
Severi G, English DR, Hopper JL, Giles GG (2006) Re: Prospective studies of dairy product and calcium intakes and prostate cancer risk: a meta-analysis. J Natl Cancer Inst 98: 794–795.
[19]
Giovannucci E, Liu Y, Stampfer MJ, Willett WC (2006) A prospective study of calcium intake and incident and fatal prostate cancer. Cancer Epidemiol Biomarkers Prev 15: 203–210.
[20]
Kesse E, Bertrais S, Astorg P, Jaouen A, Arnault N, et al. (2006) Dairy products, calcium and phosphorus intake, and the risk of prostate cancer: results of the French prospective SU.VI.MAX (Supplementation en Vitamines et Mineraux Antioxydants) study. Br J Nutr 95: 539–545.
[21]
Rodriguez C, McCullough ML, Mondul AM, Jacobs EJ, Fakhrabadi-Shokoohi D, et al. (2003) Calcium, dairy products, and risk of prostate cancer in a prospective cohort of United States men. Cancer Epidemiol Biomarkers Prev 12: 597–603.
[22]
Gao X, LaValley MP, Tucker KL (2005) Prospective studies of dairy product and calcium intakes and prostate cancer risk: a meta-analysis. J Natl Cancer Inst 97: 1768–1777.
[23]
Baron JA, Beach M, Wallace K, Grau MV, Sandler RS, et al. (2005) Risk of prostate cancer in a randomized clinical trial of calcium supplementation. Cancer Epidemiol Biomarkers Prev 14: 586–589.
[24]
Halthur C, Johansson AL, Almquist M, Malm J, Gronberg H, et al. (2009) Serum calcium and the risk of prostate cancer. Cancer Causes Control 20: 1205–1214.
[25]
Giovannucci E (1998) Dietary influences of 1,25(OH)2 vitamin D in relation to prostate cancer: a hypothesis. Cancer Causes Control 9: 567–582.
[26]
Ahn J, Albanes D, Peters U, Schatzkin A, Lim U, et al. (2007) Dairy products, calcium intake, and risk of prostate cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev 16: 2623–2630.
[27]
Almquist M, Manjer J, Bondeson L, Bondeson AG (2007) Serum calcium and breast cancer risk: results from a prospective cohort study of 7,847 women. Cancer Causes Control 18: 595–602.
[28]
Prins GS, Korach KS (2008) The role of estrogens and estrogen receptors in normal prostate growth and disease. Steroids 73: 233–244.
[29]
Skinner HG, Schwartz GG (2009) A prospective study of total and ionized serum calcium and fatal prostate cancer. Cancer Epidemiol Biomarkers Prev 18: 575–578.
[30]
Skinner HG, Schwartz GG (2008) Serum calcium and incident and fatal prostate cancer in the National Health and Nutrition Examination Survey. Cancer Epidemiol Biomarkers Prev 17: 2302–2305.
[31]
Subhas C, Venugopal R, Henry A, James V (2003) Extracellular Calcium and Calcium Sensing Receptor Function in Human Colon Carcinomas. Cancer research 63(1): 67.
[32]
Guillaume L, Sandrine H, Christian S, Etienne D, Fabien VA, et al. (2001) Ca2+ Pools and Cell Growth. Journal of Biological Chemistry 276: 47608.
